Serum hepatitis B virus RNA levels as a predictor of HBeAg seroconversion during treatment with peginterferon alfa-2a

Serum hepatitis B virus RNA levels as a predictor of HBeAg seroconversion during treatment with peginterferon alfa-2a

Abstract Background Hepatitis B e antigen (HBeAg) seroconversion represents an endpoint of treatment of chronic hepatitis B virus (HBV) infections. Methods We have studied whether levels of serum hepatitis B virus ribonucleic acid (HBV RNA) during pegylated interferon alfa-2a treatment might be help...

Full description

Bibliographic Details
Main Authors: Wen Jia, Men Qi Zhu, Xun Qi, Ting Wang, Xiao Wen, Pei Dong Chen, Qing Qi Fan, Wen-Hong Zhang, Ji Ming Zhang
Format: Article
Language:English
Published: BMC 2019-05-01
Series:Virology Journal
Subjects:
HBV RNA
Hepatitis B e antigens
Hepatitis B
Chronic
Online Access:http://link.springer.com/article/10.1186/s12985-019-1152-6

Internet

http://link.springer.com/article/10.1186/s12985-019-1152-6

Similar Items